IVAX Corp. (Active Pharmaceutical Ingredient Watch).(was 1 of 4 firms to get FDA approval for generic version of AstraZeneca's Nolvadex, tamoxifen)(Brief Article)

Chemical Market Reporter, March, 2003

IVAX Corp. was one of four companies to receive FDA approval for its generic version of AstraZeneca PLC'S 10mg and 20mg breast cancer drug Nolvadex (tamoxifen). Barr Laboratories, Mylan Laboratories and Teva Pharmaceutical Industries also received approvals.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here